With 77430.0 shares changed hands, the volume of the stock remained lighter than its average volume of 90210.0 shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $31.21 whereas the lowest price it dropped to was $29.9. The 52-week range on ELMD shows that it touched its highest point at $30.70 and its lowest point at $9.81 during that stretch. It currently has a 1-year price target of $33.00. Beta for the stock currently stands at 0.28.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ELMD was up-trending over the past week, with a rise of 6.33%, but this was up by 35.75% over a month. Three-month performance surged to 93.16% while six-month performance rose 110.01%. The stock gained 193.02% in the past year, while it has gained 184.69% so far this year. EPS is expected to grow by 15.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 20.42%.
Float and Shares Shorts:
At present, 8.64 million ELMD shares are outstanding with a float of 6.67 million shares on hand for trading. On 2024-10-31, short shares totaled 0.15 million, which was 173.0 higher than short shares on 1727654400. In addition to Mr. James L. Cunniff as the firm’s President, CEO & Director, Mr. Bradley M. Nagel serves as its CFO, Treasurer & Secretary.
Institutional Ownership:
Through their ownership of 0.36069 of ELMD’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, ELMD reported revenue of $14668000.0 and operating income of $1938000.0. The EBITDA in the recently reported quarter was $2158000.0 and diluted EPS was $0.16.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With ELMD analysts setting a high price target of 33.0 and a low target of 33.0, the average target price over the next 12 months is 33.0. Based on these targets, ELMD could surge 6.25% to reach the target high and rise by 6.25% to reach the target low. Reaching the average price target will result in a growth of 6.25% from current levels.
Analysts have provided yearly estimates in a range of $0.51 being high and $0.51 being low. For ELMD, this leads to a yearly average estimate of $0.51. The surprise factor in the prior quarter was $0.14. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
